Brainstorm Cell Therapeutics Shares Spike On Volume, Boston Globe Publishes: 'Trials for potential ALS treatment spark cautious hope' Wherein CEO Lebovits Says of NurOwn Treatment: 'We have seen wonderful results in a smaller patient population'